Skip to main content
. 2020 Apr 20;133(8):982–993. doi: 10.1097/CM9.0000000000000682

Figure 1.

Figure 1

Flow diagram of the selection of randomized controlled trials (RCTs) and prospective cohort studies treating hyperuricemia and gout with urate-lowering therapies. CQVIP: Chongqing VIP; CNKI: China National Knowledge Infrastructure; CV: Cardiovascular; ULT: Urate-lowering agent.